Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-25 @ 2:39 AM
NCT ID:
NCT04987034
Eligibility Criteria:
Inclusion Criteria:
* Patients with cirrhosis who have been referred for a procedure where HVPG is obtained.
Exclusion Criteria:
* Patient is pregnant, breast-feeding, or planning to become pregnant during the course of the study
* Patient is unwilling or unable to sign and date the informed consent
* Patient is unwilling to comply with the follow-up study schedule
* Previous total or partial splenectomy
* Non-cirrhotic portal hypertension
* Known history of spontaneous bacterial peritonitis (SBP) within the last three months irrespective of treatment for SBP
* Patients with known infection which is not controlled by medical intervention
* Portopulmonary hypertension
* Cardiac decompensation
* Pre-sinusoidal liver disease
* Cholestatic liver disease
* Patient who received endoscopic treatment for upper gastrointestinal (GI) variceal bleeding within the past 7 days
* Patients with current hepatocellular carcinoma (HCC)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT04987034
Study Brief:
Protocol Section:
NCT04987034